Purple biotech reports fourth quarter and full-year 2023 financial results

Rehovot, israel, march 05, 2024 (globe newswire) -- purple biotech ltd. ("purple biotech" or "the company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the fourth quarter and full year ended december 31, 2023.
PPBT Ratings Summary
PPBT Quant Ranking